Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesPayablesPrepaid AssetsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Journey Medical (DERM) Accumulated Expenses (2020 - 2026)

Journey Medical filings provide 6 years of Accumulated Expenses readings, the most recent being $398000.0 for Q4 2025.

  • On a quarterly basis, Accumulated Expenses fell 88.22% to $398000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $398000.0, a 88.22% decrease, with the full-year FY2025 number at $398000.0, down 88.22% from a year prior.
  • Accumulated Expenses hit $398000.0 in Q4 2025 for Journey Medical, down from $995000.0 in the prior quarter.
  • In the past five years, Accumulated Expenses ranged from a high of $26.0 million in Q3 2021 to a low of $398000.0 in Q4 2025.
  • Median Accumulated Expenses over the past 5 years was $2.6 million (2022), compared with a mean of $6.1 million.
  • Biggest five-year swings in Accumulated Expenses: skyrocketed 674.65% in 2023 and later plummeted 93.8% in 2025.
  • Journey Medical's Accumulated Expenses stood at $2.7 million in 2021, then dropped by 2.78% to $2.6 million in 2022, then skyrocketed by 674.65% to $20.3 million in 2023, then plummeted by 83.4% to $3.4 million in 2024, then plummeted by 88.22% to $398000.0 in 2025.
  • The last three reported values for Accumulated Expenses were $398000.0 (Q4 2025), $995000.0 (Q3 2025), and $990000.0 (Q2 2025) per Business Quant data.